Fresenius Purchase of NxStage Delayed Until August by FTC
The government shutdown delayed FTC approval of a Fresenius acquisition of NxStage Medical, Inc. The transaction is now expected to close in August 2019.
Read the full article » | Posted 02-14-2019
Related Articles
- Nephrologist Dr. Roberto Collazo Shares New Treatments for Kidney Disease and ESKD Posted 12-11-2024
- Ellen Lukens from CMMI Presents on the Kidney Care Choices Model Posted 12-11-2024
- 2025 NKF Survey on Kidney Health Priorities Finds Home Dialysis is a Patient Priority Posted 12-11-2024
- FDA Correction on Baxter MiniCap Extended Life PD Transfer Set Posted 12-11-2024